Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli

PLoS Pathogens

Volumn 8, Issue 5, 2012, Pages

  Xu, Xuefang ^a,g   McAteer, Sean P ^a   Tree, Jai J ^a   Shaw, Darren J ^a   Wolfson, Eliza B K ^a   Beatson, Scott A ^b   Roe, Andrew J ^c   Allison, Lesley J ^d   Chase Topping, Margo E ^e   Mahajan, Arvind ^a   Tozzoli, Rosangela ^f   Woolhouse, Mark E J ^e   Morabito, Stefano ^f   Gally, David L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g National Institute for Communicable Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN 2; ESCHERICHIA COLI PROTEIN; LEE PROTEIN, E COLI; LER PROTEIN, E COLI; PHOSPHOPROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENE DELETION; LYSOGENIZATION; NONHUMAN; REGULATORY MECHANISM; STRAIN DIFFERENCE; TYPE III SECRETION SYSTEM; ANIMAL; BACTERIAL SECRETION SYSTEM; BIOSYNTHESIS; COLIPHAGE; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; VIROLOGY;

BOS; ENTEROBACTERIACEAE; ESCHERICHIA COLI;

ANIMALS; BACTERIAL SECRETION SYSTEMS; COLIPHAGES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; LYSOGENY; PHOSPHOPROTEINS; SHIGA TOXIN 2; TRANS-ACTIVATORS;

EID: 84863658607     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002672     Document Type: Article

References (70)

1. Kaper JB, Nataro JP, Mobley HL, (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
2. Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H, (1997) Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 23: 1089-1097.
3. Lim JY, Yoon J, Hovde CJ, (2010) A brief overview of Escherichia coli O157:H7 and its plasmid O157. J Microbiol Biotechnol 20: 5-14.
4. Friedman DI, Court DL, (2001) Bacteriophage lambda: alive and well and still doing its thing. Curr Opin Microbiol 4: 201-207.
5. Waldor MK, Friedman DI, (2005) Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol 8: 459-465.
6. Boyd EF, Brussow H, (2002) Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 10: 521-529.
7. Brussow H, Canchaya C, Hardt WD, (2004) Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68: 560-602.
8. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, et al. (2009) Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 106: 17939-17944.
9. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, et al. (1997) Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511-520.
10. Kenny B, Jepson M, (2000) Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2: 579-590.
11. Nataro JP, Kaper JB, (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
12. Abe H, Miyahara A, Oshima T, Tashiro K, Ogura Y, et al. (2008) Global regulation by horizontally transferred regulators establishes the pathogenicity of Escherichia coli. DNA Res 15: 25-38.
13. Tree JJ, Wolfson EB, Wang D, Roe AJ, Gally DL, (2009) Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends Microbiol 17: 361-370.
14. Tree JJ, Roe AJ, Flockhart A, McAteer SP, Xu X, et al. (2011) Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol 80: 1349-65.
15. Flockhart AF, Tree JJ, Xu X, Karpiyevich M, McAteer SP, et al. (2012) Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion. Mol Microbiol 83: 208-223.
16. Asadulghani M, Ogura Y, Ooka T, Itoh T, Sawaguchi A, et al. (2009) The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants. PLoS Pathog 5: e1000408.
17. Sandvig K, (2001) Shiga toxins. Toxicon 39: 1629-1635.
18. Lindberg AA, Brown JE, Stromberg N, Westlingryd M, Schultz JE, et al. (1987) Identification of the Carbohydrate Receptor for Shiga Toxin Produced by Shigella-Dysenteriae Type-1. J Bio Chem 262: 1779-1785.
19. Lingwood CA, (1999) Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. Biochim Biophys Acta 1455: 375-386.
20. Law D, (2000) Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli. J Appl Microbiol 88: 729-745.
21. Proulx F SE, Karpman D, (2001) Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50: 163-71.
22. Tarr PI, Gordon CA, Chandler WL, (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086.
23. Hancock DD, Besser TE, Kinsel ML, Tarr PI, Rice DH, et al. (1994) The prevalence of Escherichia coli O157.H7 in dairy and beef cattle in Washington State. Epidemiol Infect 113: 199-207.
24. Cherifi A, Contrepois M, Picard B, Goullet P, Orskov I, et al. (1994) Clonal relationships among Escherichia coli serogroup O78 isolates from human and animal infections. J Clin Microbiol 32: 1197-1202.
25. Orskov F, Orskov I, Villar JA, (1987) Cattle as reservoir of verotoxin-producing Escherichia coli O157:H7. Lancet 2: 276.
26. Geue L, Klare S, Schnick C, Mintel B, Meyer K, et al. (2009) Analysis of the clonal relationship of serotype O26:H11 enterohemorrhagic Escherichia coli isolates from cattle. Appl Environ Microbiol 75: 6947-6953.
27. Chapman PA, Siddons CA, Wright DJ, Norman P, Fox J, et al. (1993) Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect 111: 439-447.
28. Synge BA, (2000) Verocytotoxin-producing Escherichia coli: a veterinary view. Symp Ser Soc Appl Microbiol pp. 31S-37S.
29. Hoey DE, Currie C, Else RW, Nutikka A, Lingwood CA, et al. (2002) Expression of receptors for verotoxin 1 from Escherichia coli O157 on bovine intestinal epithelium. J Med Microbiol 51: 143-149.
30. Hoey DE, Sharp L, Currie C, Lingwood CA, Gally DL, et al. (2003) Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol 5: 85-97.
31. Pruimboom-Brees IM, Morgan TW, Ackermann MR, Nystrom ED, Samuel JE, et al. (2000) Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci U S A 97: 10325-10329.
32. Robinson CM, Sinclair JF, Smith MJ, O'Brien AD, (2006) Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A 103: 9667-9672.
33. Gobert AP, Vareille M, Glasser AL, Hindré T, de Sablet T, et al. (2007) Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-kappaB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. J Immunol 178: 8168-74.
34. Menge C, Wieler LH, Schlapp T, Baljer G, (1999) Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro. Infect Immun 67: 2209-17.
35. Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, et al. (2010) NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A 107: 3129-34.
36. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, et al. (2010) The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 6: e1000898.
37. Nadler C, Baruch K, Kobi S, Mills E, Haviv G, et al. (2010) The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog 29: e1000743.
38. Gao X, Wan F, Mateo K, Callegari E, Wang D, et al. (2009) Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog 5: e1000708.
39. Mühlen S, Ruchaud-Sparagano MH, Kenny B, (2011) Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli. J Biol Chem 286: 5100-7.
40. Manning SD, Motiwala AS, Springman AC, Qi W, Lacher DW, et al. (2008) Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci USA 105: 4868-4873.
41. Pearce MC, Chase-Topping ME, McKendrick IJ, Mellor DJ, Locking ME, et al. (2009) Temporal and spatial patterns of bovine Escherichia coli O157 prevalence and comparison of temporal changes in the patterns of phage types associated with bovine shedding and human E. coli O157 cases in Scotland between 1998-2000 and 2002-2004. BMC Microbiol 9: 276.
42. Chase-Topping ME, McKendrick IJ, Pearce MC, MacDonald P, Matthews L, et al. (2007) Risk factors for the presence of high-level shedders of Escherichia coli O157 on Scottish farms. J Clin Microbiol 45: 1594-1603.
43. Naylor SW, Low JC, Besser TE, Mahajan A, Gunn GJ, et al. (2003) Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect Immun 71: 1505-12.
44. Chase-Topping M, Gally D, Low C, Matthews L, Woolhouse M, (2008) Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157. Nat Rev Microbiol 6: 904-912.
45. Roe AJ, Yull H, Naylor SW, Woodward MJ, Smith DG, et al. (2003) Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the post transcriptional level. Infect Immun 71: 5900-5909.
46. Campellone KG, Roe AJ, Lobner-Olesen A, Murphy KC, Magoun L, et al. (2007) Increased adherence and actin pedestal formation by dam-deficient enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 63: 1468-1481.
47. Mellmann A, Bielaszewska M, Kock R, Friedrich AW, Fruth A, et al. (2008) Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 14: 1287-1290.
48. Perna NT, Plunkett G 3rd, Burland V, Mau B, Glasner JD, et al. (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409: 529-533.
49. Zhang Y, Laing C, Zhang Z, Hallewell J, You C, et al. (2009) Lineage and host source are both correlated with levels of Shiga toxin 2 production by Escherichia coli O157:H7 strains. Appl Environ Microbiol 76: 474-482.
50. Muniesa M, Blanco JE, De Simon M, Serra-Moreno R, Blanch AR, et al. (2004) Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle. Microbiol 150: 2959-2971.
51. Fogg PC, Saunders JR, McCarthy AJ, Allison HE, (2011) Cumulative effect of prophage burden on Shiga toxin production in Escherichia coli. Microbiol 158: 488-97.
52. Oppenheim AB, Kobiler O, Stavans J, Court DL, Adhya S, (2005) Switches in bacteriophage lambda development. Annu Rev Genet 39: 409-429.
53. Roe AJ, Naylor SW, Spears KJ, Yull HM, Dransfield TA, et al. (2004) Co-ordinate single-cell expression of LEE4- and LEE5-encoded proteins of Escherichia coli O157:H7. Mol Microbiol 54: 337-352.
54. Yang Z, Kim J, Zhang C, Zhang M, Nietfeldt J, et al. (2009) Genomic instability in regions adjacent to a highly conserved pch prophage in Escherichia coli O157:H7 generates diversity in expression patterns of the LEE pathogenicity island. J Bacteriol 191: 3553-3568.
55. Su LK, Lu CP, Wang Y, Cao DM, Sun JH, et al. (2010) Lysogenic infection of a Shiga toxin 2-converting bacteriophage changes host gene expression, enhances host acid resistance and motility. Mol Biol (Mosk) 44: 60-73.
56. Tatsuno I, Nagano K, Taguchi K, Rong L, Mori H, et al. (2003) Increased adherence to Caco-2 cells caused by disruption of the yhiE and yhiF genes in enterohemorrhagic Escherichia coli O157:H7. Infect Immun 71: 2598-2606.
57. Kailasan Vanaja S, Bergholz TM, Whittam TS, (2009) Characterization of the Escherichia coli O157:H7 Sakai GadE regulon. J Bacteriol 191: 1868-1877.
58. Mellies JL, Haack KR, Galligan DC, (2007) SOS regulation of the type III secretion system of enteropathogenic Escherichia coli. J Bacteriol 189: 2863-2872.
59. Kedzierska B, Glinkowska M, Iwanicki A, Obuchowski M, Sojka P, et al. (2003) Toxicity of the bacteriophage lambda cII gene product to Escherichia coli arises from inhibition of host cell DNA replication. Virology 313: 622-628.
60. Iyoda S, Watanabe H, (2005) ClpXP protease controls expression of the type III protein secretion system through regulation of RpoS and GrlR levels in enterohemorrhagic Escherichia coli. J Bacteriol 187: 4086-4094.
61. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, et al. (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 103: 14941-14946.
62. Liu B, Yin X, Feng Y, Chambers JR, Guo A, et al. (2010) Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells. Appl Environ Microbiol 76: 4461-4468.
63. Sperandio V, (2010) SdiA sensing of acyl-homoserine lactones by enterohemorrhagic E. coli (EHEC) serotype O157:H7 in the bovine rumen. Gut Microbes 1: 432-5.
64. Wang G, Clark CG, Rodgers FG, (2002) Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR. J Clin Microbiol 40: 3613-3619.
65. Naylor SW, Roe AJ, Nart P, Spears K, Smith DG, et al. (2005) Escherichia coli O157:H7 forms attaching and effacing lesions at the terminal rectum of cattle and colonization requires the LEE4 operon. Microbiol 151: 2773-2781.
66. Emmerson JR, Gally DL, Roe AJ, (2006) Generation of gene deletions and gene replacements in Escherichia coli O157:H7 using a temperature sensitive allelic exchange system. Biol Proced Online 8: 153-162.
67. Dahan S, Knutton S, Shaw RK, Crepin VF, Dougan G, et al. (2004) Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes. Infect Immun 72: 5452-5459.
68. Merlin C, Gardiner G, Durand S, Masters M, (2002) The Escherichia coli metD locus encodes an ABC transporter which includes Abc (MetN), YaeE (MetI), and YaeC (MetQ). J Bacteriol 184: 5513-5517.
69. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nuc Acids Res 9: e36.
70. Blomfield IC, Vaughn V, Rest RF, Eisenstein BI, (1991) Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol Microbiol 5: 1447-1457.